Febentel 888 mg

For its established antiparasitic use, fenbendazole disrupts important processes that susceptible worms need to survive. This helps control worm infections when the correct product and instructions are followed.

Its potential cancer-related benefits remain an area of scientific investigation. Laboratory and animal studies have examined its ability to:

• Disrupt cancer-cell division

• Affect microtubule formation

• Reduce glucose uptake by cancer cells

• Interfere with cellular energy production

• Influence proteins involved in abnormal cell growth

• Support further drug-repurposing research

A 2018 laboratory study reported activity against human cancer cells and reduced tumour growth in a mouse model. These results support continued research but do not prove that fenbendazole provides the same benefits in people.

COVID-19 research involving fenbendazole has been limited to early computer modelling. No clinical benefit has been demonstrated in people.

Fenbendazole binds to tubulin, a protein required to build structures called microtubules. Susceptible worms need these structures to absorb glucose, produce energy and maintain essential cellular functions. Disrupting this process gradually depletes their energy and causes them to die.

Cancer researchers are studying whether similar activity can affect rapidly dividing cancer cells. Laboratory experiments found that fenbendazole disrupted microtubules, reduced glucose uptake and affected cellular energy pathways. Changes involving p53, a protein that helps control damaged cells, were also observed.

For COVID-19, computer-based studies have explored whether fenbendazole can interact with parts of the SARS-CoV-2 virus. Computer predictions cannot show whether a medicine is safe or effective in the human body, so laboratory and controlled human studies are still required.

The 888 mg strength describes the amount of fenbendazole in each tablet. It does not represent an established human dose for cancer, COVID-19 or parasitic infections.

There is no clinically established human cancer or COVID-19 dosage for Febentel 888 mg. Online schedules recommending daily doses, treatment cycles or combinations with vitamins have not been validated through controlled human trials.

The high tablet strength does not mean it will work better for an unapproved use. Do not take, divide or combine Febentel 888 mg tablets based on online testimonials or another person’s schedule.

Anyone considering or already taking fenbendazole should tell their healthcare or oncology team the exact product strength, amount and frequency. Prescribed cancer treatment, antiviral treatment or other medical care should not be stopped or changed.

Common Side Effects: Reliable rates of human side effects are unavailable because fenbendazole has not completed adequate clinical safety studies for these uses. Digestive discomfort, nausea, diarrhoea, reduced appetite, rash or allergic symptoms have been reported, but their frequency in people cannot be stated with confidence.

Serious Side Effects: Published human case reports have linked self-administered fenbendazole with drug-induced liver injury. Warning signs include yellow skin or eyes, dark urine, persistent nausea, loss of appetite, unusual tiredness and pain in the upper-right abdomen. Severe rash, facial swelling or difficulty breathing also requires urgent medical attention.

Febentel 888 mg should not be used for cancer or COVID-19 self-treatment. Particular concern applies to:

• People with liver disease

• People with abnormal liver tests

• People receiving chemotherapy

• People receiving immunotherapy

• People taking antiviral medicines

• Pregnant or breastfeeding women

• Children and adolescents

• People allergic to benzimidazoles

• People enrolled in clinical trials

Human interaction studies involving fenbendazole are limited. Tell the healthcare or oncology team about every medicine, supplement and herbal product being used.

Important combinations requiring medical review include:

• Chemotherapy medicines

• Immunotherapy medicines

• Targeted cancer treatments

• Hormonal cancer treatments

• Antiviral medicines

• Medicines that affect the liver

• Other benzimidazole medicines

• Herbal remedies and supplements

Do not combine fenbendazole with cancer or COVID-19 treatment without professional review. Undisclosed use can make it difficult to determine whether abnormal liver tests or other reactions are caused by the prescribed treatment or fenbendazole.

• Keep the tablets in their original packaging.

• Follow the storage temperature printed on the pack.

• Protect the tablets from heat, moisture and sunlight.

• Keep them away from children and pets.

• Do not use tablets from damaged or unsealed packaging.

• Check the batch number and expiry date before use.

• Dispose of expired tablets according to local requirements.